| From genome-wide associations to candidate causal variants by statistical fine-mapping DJ Schaid, W Chen, NB Larson Nature Reviews Genetics 19 (8), 491-504, 2018 | 434 | 2018 |
| Risk SNP-mediated promoter-enhancer switching drives prostate cancer through lncRNA PCAT19 JT Hua, M Ahmed, H Guo, Y Zhang, S Chen, F Soares, J Lu, S Zhou, ... Cell 174 (3), 564-575. e18, 2018 | 193 | 2018 |
| Complementation contributes to transcriptome complexity in maize (Zea mays L.) hybrids relative to their inbred parents A Paschold, Y Jia, C Marcon, S Lund, NB Larson, CT Yeh, S Ossowski, ... Genome research 22 (12), 2445-2454, 2012 | 137 | 2012 |
| Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2 and RAD51C status JM Cunningham, MS Cicek, NB Larson, J Davila, C Wang, MC Larson, ... Scientific reports 4 (1), 1-7, 2014 | 127 | 2014 |
| PurBayes: estimating tumor cellularity and subclonality in next-generation sequencing data NB Larson, BL Fridley Bioinformatics 29 (15), 1888-1889, 2013 | 78 | 2013 |
| Associations of mitochondrial and nuclear mitochondrial variants and genes with seven metabolic traits AT Kraja, C Liu, JL Fetterman, M Graff, CT Have, C Gu, LR Yanek, ... The American Journal of Human Genetics 104 (1), 112-138, 2019 | 72 | 2019 |
| Identification of candidate genes for prostate cancer-risk SNPs utilizing a normal prostate tissue eQTL data set SN Thibodeau, AJ French, SK McDonnell, J Cheville, S Middha, ... Nature communications 6 (1), 1-10, 2015 | 60 | 2015 |
| Nonsyntenic genes drive highly dynamic complementation of gene expression in maize hybrids A Paschold, NB Larson, C Marcon, JC Schnable, CT Yeh, C Lanz, ... The Plant Cell 26 (10), 3939-3948, 2014 | 58 | 2014 |
| P-selectin and subclinical and clinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA) SJ Bielinski, C Berardi, PA Decker, PS Kirsch, NB Larson, JS Pankow, ... Atherosclerosis 240 (1), 3-9, 2015 | 55 | 2015 |
| Kernel canonical correlation analysis for assessing gene–gene interactions and application to ovarian cancer NB Larson, GD Jenkins, MC Larson, RA Vierkant, TA Sellers, CM Phelan, ... European Journal of Human Genetics 22 (1), 126-131, 2014 | 42 | 2014 |
| Comprehensively evaluating cis-regulatory variation in the human prostate transcriptome by using gene-level allele-specific expression NB Larson, S McDonnell, AJ French, Z Fogarty, J Cheville, S Middha, ... The American Journal of Human Genetics 96 (6), 869-882, 2015 | 38 | 2015 |
| Improvement in cardiovascular risk prediction with electronic health records MM Pike, PA Decker, NB Larson, JL St Sauver, PY Takahashi, VL Roger, ... Journal of cardiovascular translational research 9 (3), 214-222, 2016 | 37 | 2016 |
| A robust e-epidemiology tool in phenotyping heart failure with differentiation for preserved and reduced ejection fraction: the electronic medical records and genomics (eMERGE … SJ Bielinski, J Pathak, DS Carrell, PY Takahashi, JE Olson, NB Larson, ... Journal of cardiovascular translational research 8 (8), 475-483, 2015 | 35 | 2015 |
| A kernel regression approach to gene‐gene interaction detection for case‐control studies NB Larson, DJ Schaid Genetic epidemiology 37 (7), 695-703, 2013 | 35 | 2013 |
| CYP2D6 phenotypes are associated with adverse outcomes related to opioid medications JL St Sauver, JE Olson, VL Roger, WT Nicholson, JL Black III, ... Pharmacogenomics and Personalized Medicine 10, 217, 2017 | 34 | 2017 |
| ABO blood group associations with markers of endothelial dysfunction in the Multi-Ethnic Study of Atherosclerosis NB Larson, EJ Bell, PA Decker, M Pike, CL Wassel, MY Tsai, JS Pankow, ... Atherosclerosis 251, 422-429, 2016 | 34 | 2016 |
| Yield of the RYR2 Genetic Test in Suspected Catecholaminergic Polymorphic Ventricular Tachycardia and Implications for Test Interpretation JD Kapplinger, KN Pundi, NB Larson, TE Callis, DJ Tester, H Bikker, ... Circulation: Genomic and Precision Medicine 11 (2), e001424, 2018 | 33 | 2018 |
| Atherosclerotic cardiovascular disease risk stratification based on measurements of troponin and coronary artery calcium Y Sandoval, SJ Bielinski, LB Daniels, MJ Blaha, ED Michos, AP DeFilippis, ... Journal of the American College of Cardiology 76 (4), 357-370, 2020 | 28 | 2020 |
| Circulating level of hepatocyte growth factor predicts incidence of type 2 diabetes mellitus: the Multi-Ethnic Study of Atherosclerosis (MESA) MP Bancks, SJ Bielinski, PA Decker, NQ Hanson, NB Larson, H Sicotte, ... Metabolism 65 (3), 64-72, 2016 | 26 | 2016 |
| Cohort profile: the right drug, right dose, right time: using genomic data to individualize treatment protocol (RIGHT protocol) SJ Bielinski, JL St Sauver, JE Olson, NB Larson, JL Black III, SE Scherer, ... International journal of epidemiology 49 (1), 23-24k, 2020 | 25 | 2020 |
Suzette J. BielinskiMayo ClinicПотвърден имейл адрес: umn.edu
